Menu

Filtros : "European Heart Journal" "LIPOPROTEÍNAS LDL" Removido: "2000" Limpar

Filtros

Limitar por data

  • 1

1 - 2 (2 registros)

  • Trabalho de evento-resumo periodico

    Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population (2015)

    Cesena, F. H.; Laurinavicius, A. G.; Bittencourt, M. S.; Conceicao, R. D.; Santos, R. D.

    Fonte: European Heart Journal. Nome do evento: ESC Congress. Unidades: HU, FM

    Assuntos: LIPOPROTEÍNAS LDL, FATORES DE RISCO, RESUMOS (EVENTOS)

    Acesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CESENA, F. H. et al. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population. European Heart Journal. London: Hospital Universitário, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf. Acesso em: 06 nov. 2024. , 2015

    • APA

      Cesena, F. H., Laurinavicius, A. G., Bittencourt, M. S., Conceicao, R. D., & Santos, R. D. (2015). Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population. European Heart Journal. London: Hospital Universitário, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf

    • NLM

      Cesena FH, Laurinavicius AG, Bittencourt MS, Conceicao RD, Santos RD. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population [Internet]. European Heart Journal. 2015 ; 36 2.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf

    • Vancouver

      Cesena FH, Laurinavicius AG, Bittencourt MS, Conceicao RD, Santos RD. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population [Internet]. European Heart Journal. 2015 ; 36 2.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf

  • Trabalho de evento-resumo periodico

    Oxidized LDL is increased in the liver of non hepatic disease patients and it may contributes for development of vulnerable plaques with low PPAR gamma content (2010)

    Higuchi, Maria de Lourdes; Boteon, E. M; Reis, M. M; Palomino, Suely Aparecida Pinheiro; Ikegami, R; Otsubo, Roberto; Mauad, Thais; Abdalla, Dulcinéia Saes Parra ; Ramires, José A. Franchini

    Fonte: European Heart Journal. Nome do evento: ESC Congress. Unidades: FM, FCF

    Assunto: LIPOPROTEÍNAS LDL

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HIGUCHI, Maria de Lourdes et al. Oxidized LDL is increased in the liver of non hepatic disease patients and it may contributes for development of vulnerable plaques with low PPAR gamma content. European Heart Journal. oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2010

    • APA

      Higuchi, M. de L., Boteon, E. M., Reis, M. M., Palomino, S. A. P., Ikegami, R., Otsubo, R., et al. (2010). Oxidized LDL is increased in the liver of non hepatic disease patients and it may contributes for development of vulnerable plaques with low PPAR gamma content. European Heart Journal. oxford: Faculdade de Medicina, Universidade de São Paulo.

    • NLM

      Higuchi M de L, Boteon EM, Reis MM, Palomino SAP, Ikegami R, Otsubo R, Mauad T, Abdalla DSP, Ramires JAF. Oxidized LDL is increased in the liver of non hepatic disease patients and it may contributes for development of vulnerable plaques with low PPAR gamma content. European Heart Journal. 2010 ; 31 796 res. P4634.[citado 2024 nov. 06 ]

    • Vancouver

      Higuchi M de L, Boteon EM, Reis MM, Palomino SAP, Ikegami R, Otsubo R, Mauad T, Abdalla DSP, Ramires JAF. Oxidized LDL is increased in the liver of non hepatic disease patients and it may contributes for development of vulnerable plaques with low PPAR gamma content. European Heart Journal. 2010 ; 31 796 res. P4634.[citado 2024 nov. 06 ]
  • 1

1 - 2 (2 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024